Georg Stingl Selected Research

Georg Stingl Research Topics

Disease

16	Neoplasms (Cancer) 03/2022 - 11/2002
15	Atopic Dermatitis (Atopic Eczema) 10/2023 - 04/2002
14	Inflammation (Inflammations) 11/2020 - 02/2002
9	Melanoma (Melanoma, Malignant) 01/2013 - 11/2003
8	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 11/2006
6	Skin Diseases (Skin Disease) 10/2019 - 05/2002
5	Autoimmune Diseases (Autoimmune Disease) 07/2020 - 12/2006
5	Asthma (Bronchial Asthma) 01/2004 - 02/2002
4	Disease Progression 01/2021 - 12/2006
4	Stevens-Johnson Syndrome (Lyell's Syndrome) 07/2020 - 04/2007
4	Pneumonia (Pneumonitis) 01/2004 - 02/2002
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2020 - 01/2014
3	Bullous Pemphigoid (Pemphigoid) 12/2019 - 02/2003
3	Neoplasm Metastasis (Metastasis) 01/2013 - 12/2008
3	Respiratory Hypersensitivity 01/2004 - 05/2002
2	Infections 03/2022 - 05/2012
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 09/2003
2	Syphilis 10/2019 - 11/2005
2	Tuberculosis (Tuberculoses) 01/2018 - 04/2009
2	Chronic Urticaria 10/2017 - 09/2002
2	Pemphigus (Pemphigus Vulgaris) 05/2015 - 12/2006
2	Contact Dermatitis (Eczema, Contact) 03/2010 - 11/2003
2	Acute Disease 11/2002 - 02/2002
1	Eczema 10/2023
1	Pruritus (Itching) 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Wells syndrome 07/2018
1	Acne Vulgaris 01/2017
1	Hyperplasia 01/2017
1	Alopecia Areata 01/2017
1	Weight Gain 01/2017
1	Neutropenia 10/2015
1	Candidiasis (Moniliasis) 10/2015
1	Body Weight (Weight, Body) 10/2015
1	Lichen Planus (Lichen Ruber Planus) 07/2015
1	Atrophy 06/2015

Drug/Important Bio-Agent (IBA)

13	Immunoglobulin E (IgE)IBA 10/2023 - 04/2002
9	AutoantibodiesIBA 12/2019 - 04/2002
9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 02/2003
6	AllergensIBA 01/2011 - 02/2002
6	AntigensIBA 07/2009 - 02/2002
5	pimecrolimus (Elidel)FDA Link 06/2015 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2002
4	Intravenous Immunoglobulins (IVIG)FDA Link 07/2020 - 09/2009
4	Imiquimod (Aldara)FDA LinkGeneric 07/2015 - 09/2004
4	AerosolsIBA 01/2004 - 02/2002
4	Immunoglobulin G (IgG)IBA 01/2004 - 05/2002
3	Ustekinumab (CNTO 1275)FDA Link 03/2022 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2006
3	CytokinesIBA 11/2020 - 09/2008
3	AntibodiesIBA 10/2019 - 12/2005
3	Interleukin-4 (Interleukin 4)IBA 07/2015 - 05/2002
3	Immunoglobulins (Immunoglobulin)IBA 09/2009 - 02/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023 - 04/2002
2	anti-IgE antibodiesIBA 10/2023 - 09/2002
2	brodalumabIBA 03/2022 - 10/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2020
2	Immunoglobulin A (IgA)IBA 09/2020 - 12/2006
2	Omalizumab (Xolair)FDA Link 10/2017 - 12/2010
2	InterleukinsIBA 01/2017 - 07/2015
2	Interleukin-12 (IL 12)IBA 01/2017 - 11/2013
2	Interleukin-17 (Interleukin 17)IBA 07/2015 - 07/2015
2	LigandsIBA 07/2015 - 04/2007
2	sonidegibIBA 01/2013 - 08/2011
2	Mitogen-Activated Protein KinasesIBA 01/2013 - 11/2012
2	Rituximab (Mabthera)FDA Link 05/2012 - 06/2008
2	efalizumab (Raptiva)FDA Link 12/2010 - 11/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2010 - 01/2004
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2007 - 12/2006
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2005 - 07/2003
2	VaccinesIBA 08/2004 - 11/2003
2	EpitopesIBA 09/2003 - 11/2002
1	ligelizumabIBA 10/2023
1	Niclosamide FDA Link 01/2022
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Galectin 3 (LGALS3)IBA 11/2020
1	Complement System Proteins (Complement)IBA 12/2019
1	TNT009IBA 12/2019
1	sutimlimabIBA 12/2019
1	mepolizumabIBA 07/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 06/2017
1	SteroidsIBA 01/2017
1	Monoclonal AntibodiesIBA 10/2015
1	CC ChemokinesIBA 07/2015
1	Interleukin-12 Subunit p40IBA 07/2015
1	secukinumabIBA 07/2015
1	ChemokinesIBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015

Therapy/Procedure

14	Therapeutics 12/2019 - 02/2003
3	Hematopoietic Stem Cell Transplantation 11/2020 - 01/2014
2	Radiotherapy 05/2012 - 01/2005
2	Immunotherapy 01/2011 - 09/2004
2	Subcutaneous Injections 12/2006 - 11/2003
1	Art Therapy 12/2021
1	Lipectomy (Liposuction) 11/2020
1	Aftercare (After-Treatment) 01/2017